BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24122873)

  • 21. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
    Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
    Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-α activation in cultured human female hepatocytes.
    McIntosh AL; Huang H; Storey SM; Landrock KK; Landrock D; Petrescu AD; Gupta S; Atshaves BP; Kier AB; Schroeder F
    Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G164-76. PubMed ID: 24875102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
    Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
    Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.
    Cwinn MA; Jones SP; Kennedy SW
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Aug; 148(2):165-71. PubMed ID: 18565798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAB10 Interacts with ABCB4 and Regulates Its Intracellular Traffic.
    Ben Saad A; Vauthier V; Lapalus M; Mareux E; Bennana E; Durand-Schneider AM; Bruneau A; Delaunay JL; Gonzales E; Housset C; Aït-Slimane T; Guillonneau F; Jacquemin E; Falguières T
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
    Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
    J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detergent screening and purification of the human liver ABC transporters BSEP (ABCB11) and MDR3 (ABCB4) expressed in the yeast Pichia pastoris.
    Ellinger P; Kluth M; Stindt J; Smits SH; Schmitt L
    PLoS One; 2013; 8(4):e60620. PubMed ID: 23593265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.
    Gallucci GM; Trottier J; Hemme C; Assis DN; Boyer JL; Barbier O; Ghonem NS
    Hepatol Commun; 2021 Dec; 5(12):2035-2051. PubMed ID: 34558841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of membrane microdomains for bile salt-dependent biliary lipid secretion.
    Eckstein J; Holzhütter HG; Berndt N
    J Cell Sci; 2018 Mar; 131(5):. PubMed ID: 29420298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy.
    Ghosh A; Corbett GT; Gonzalez FJ; Pahan K
    J Biol Chem; 2012 Nov; 287(46):38922-35. PubMed ID: 22989886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human NPC1L1 expression is positively regulated by PPARα.
    Iwayanagi Y; Takada T; Tomura F; Yamanashi Y; Terada T; Inui K; Suzuki H
    Pharm Res; 2011 Feb; 28(2):405-12. PubMed ID: 20953676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-carnitine and PPARα-agonist fenofibrate are involved in the regulation of Carnitine Acetyltransferase (CrAT) mRNA levels in murine liver cells.
    Kienesberger K; Pordes AG; Völk TG; Hofbauer R
    BMC Genomics; 2014 Jun; 15(1):514. PubMed ID: 24962334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
    Trauner M; Fickert P; Wagner M
    Semin Liver Dis; 2007 Feb; 27(1):77-98. PubMed ID: 17295178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of genetic variations in the MDR3 promoter.
    Jang GH; Kim TH; Choe Y; Ham A; Choi JH
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1312-8. PubMed ID: 23261441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
    Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
    Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The peroxisome proliferator-activated receptor alpha activator fenofibrate inhibits endothelin-1-induced cardiac fibroblast proliferation.
    Ogata T; Miyauchi T; Irukayama-Tomobe Y; Takanashi M; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S279-82. PubMed ID: 15838301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
    Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
    Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-α.
    Tateno C; Yamamoto T; Utoh R; Yamasaki C; Ishida Y; Myoken Y; Oofusa K; Okada M; Tsutsui N; Yoshizato K
    Toxicol Pathol; 2015 Feb; 43(2):233-48. PubMed ID: 25107573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABCB4 disease: Many faces of one gene deficiency.
    Sticova E; Jirsa M
    Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.